Anti inflammatory drugs linked with reduced breast cancer risk
Largest review of its kind associates anti-inflammatory drugs with reduced breast cancer risk – Analysis of data from 38 studies that enrolled more than 2.7 million women ? the largest of its kind ? by researchers at the University of British Columbia, Vancouver Coastal Health Research Institute, and the University of Santiago de Compostela reveals that regular use of Non Steroidal Anti-Inflammatory Drugs (NSAIDs) is associated with a 12 per cent relative risk reduction in breast cancer compared to non-users.